| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC3595 |
| Trial ID | NCT06049381 |
| Disease | Relapsed Non-Hodgkin's Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LY007 |
| Recruitment status | Not Recruiting |
| Title | Tumor Microenvironment Mechanism of LY007 Cell Injection for the Treatment of Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma and the Exploration of Novel CAR-T Translational Research |
| Year | 2023 |
| Country | China |
| Company sponsor | Ruijin Hospital |
| Other ID(s) | LYCAR-01 |
| Cohort 1 | |||||||
|
|||||||